Acorda Therapeutics, Inc.
$0.01-$0.00 (-24.81%)
Acorda Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.94% below the high.
OTC · MOSTQ · USD
Stock price
Quote as of May 19, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
MobileSmith, Inc. specializes in developing software solutions for the United States' healthcare industry. These offerings comprise a cloud-based suite of applications, engineered to operate within a dedicated healthcare technology ecosystem. Key products include "PeriOp Patient Adherence," a mobile application that integrates with Electronic Medical Records (EMRs) to deliver pre- and post-operative instructions, thereby facilitating a crucial two-way communication channel between patients and their healthcare providers. Additionally, their portfolio features "COVID Response Mobile Apps," designed to assist hospitals and their communities in managing COVID-19 related communications, and "COVIDClear," a tool for assessing and monitoring the COVID-19 status of an organization's workforce. Established in 1993 as Smart Online, Inc., the company, now known as MobileSmith, Inc., maintains its headquarters in Raleigh, North Carolina. However, on October 12, 2022, MobileSmith, Inc. sought protection and reorganization under Chapter 11 by filing a voluntary petition with the U.S. Bankruptcy Court for the Eastern District of North Carolina.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.01-$0.00 (-24.81%)
Acorda Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.94% below the high.
$0.00$0.00 (0.0%)
MagForce AG: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
Nanomix Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
NeonMind Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
$0.00$0.00 (0.0%)
EastWest Bioscience Inc.: Healthcare · Medical - Pharmaceuticals.
$0.00$0.00 (0.0%)
Gelesis Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00-$0.04 (-99.5%)
E-Qure Corp.: Healthcare · Medical - Devices.
$0.00+$0.00 (+9,900.0%)
Gene Biotherapeutics, Inc.: Healthcare · Biotechnology.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.